Societe Generale’s Novartis NVS Stock Holding History

Societe Generale’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$4.79M	Buy	+64,736	New	+$4.47M	0.03%	411

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Societe Generale's NVS Position: Q2 2016 in Review

Societe Generale opened a new position in Novartis (NVS) in Q2 2016: 64,736 shares worth $4.79M. The stake represents 0.03% of the portfolio and ranks #411 among its holdings.

878 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

Societe Generale held 64,736 shares of Novartis worth $4.79M as of Q2 2016.
Novartis was a new Societe Generale position in Q2 2016.
Novartis made up 0.03% of Societe Generale's portfolio in Q2 2016, its #411 holding.
878 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.